Pharmacist intervention in risk reduction study in high-risk cardiac patients: The effect of 2 methods of pharmacist training

Canadian Pharmacists Journal

Volumn 140, Issue 2, 2007, Pages 116-123

  Taylor, Jeffrey ^a   Semchuk, William ^b   Deschamps, M ^c   Sulz, L ^b   Tsuyuki, Ross T ^d   Duffy, P ^b,e   Wilson, T ^e  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b REGINA QU APPELLE HEALTH REGION   (Canada)

^c CFB Gagetown   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; MALE; PHARMACIST; PHYSICIAN; PRIMARY MEDICAL CARE; REIMBURSEMENT; RISK FACTOR; RISK REDUCTION;

EID: 33947430475     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.1177/171516350714000227     Document Type: Article

References (42)

1. Keeley JL. Pharmacist scope of practice. Ann Intern Med 2002;136:79-85.
2. Romanow RJ. Building on values: the future of health care in Canada - Final Report. Ottawa: Government of Canada; 2002.
3. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes (Cochrane Review). Oxford (UK): The Cochrane Library; 2002.
4. Olson KL, Rasmussen J, Sandhoff BG, et at. Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Arch Intern Med 2005;165:49-54.
5. Ryan-Wooley B, Cantrill J, Noyce P, et al. A partnership between community pharmacists and general practitioners in the management of ischaemic heart disease: a feasibility study. Pharm J 2001;267:355-8.
6. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002;162:1149-55.
7. Herborg H, Soendergaard B, Jorgensen T, et al. Improving drug therapy for patients with asthma - Part 2. J Am Pharm Assoc 2001;41:551-9.
8. Feifer RA, Gutierrez B, Verbrugge RR. Impacts of a PBM-based disease management program on asthma medications. J Manag Care Pharm 2001;7:460-7.
9. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med 2003;25:144-53.
10. Kaufman DM, McClaran J, Toombs M, et al. Achieving cardiovascular health through continuing interprofessional development. Can J Public Health 2001;92:110-116.
11. McAlister FA, Lawson FM, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001;323:957-62.
12. Bradshaw J, Neubauer S, Karakochuk M. Impact of a pharmacist-managed, cardiovascular risk-reduction program in a family medicine practice. Can Pharm J 2005;138:34.
13. Wolfe K. Alberta pilot tackles cardiovascular health. Pharmacy Post 2005;13:14.
14. Pora V, Farrell B, Dolovich L, et al. Promoting cardiovascular health among older adults: a pilot study with community pharmacists. Can Pharm J 2005;138:50-5.
15. Lalonde L, Grover SA, O'Connor AM, et al. Evaluation of a decision aid for patients at high risk of cardiovascular disease: OPTION pilot study (abstract). Can Pharm J 2004;137:29.
16. Holland RW, Nimmo CM. Transitions - Part 1: beyond pharmaceutical care. Am J Health Syst Pharm 1999;56:1758-64.
17. Rouse MJ. Continuing professional development in pharmacy. Am J Health Syst Pharm 2004;61:2069-76.
18. Davis D, Thomson MA, Freemantle N, et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behaviour or health care outcomes? JAMA 1999;282:867-74.
19. Tu K, Davis D. Can we alter physician behavior by educational methods? Lessons learned from studies of the management and follow-up of hypertension. J Cont Educ Health Prof 2002;22:11-22.
20. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: An overview of systematic reviews of interventions. Med Care 2001;38:112-45.
21. Annaswamy R, Gomes H, Beard J, et al. A randomized trial comparing intensive and passive education in patients with diabetes mellitus. Arch Intern Med 2002;162:1301-4.
22. Watson MC, Bond CM, Grimshaw JM, et al. Educational Strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial (RCT). Fam Pract 2002;19:529-36.
23. Semchuk W, Taylor J, Sulz L, et al. Pharmacist Intervention in Risk Reduction study: high-risk cardiac patients. Can Pharm J 2007;140(1):32-7
24. Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: 2003 update. CMAJ 2003;168:921-4.
25. Ruston A. Achieving re-professionalisation: factors that influence the adoption of an "Extended Role" by community pharmacists. A national survey. J Soc Admin Pharm 2001;18:103-10.
26. Huyghebaert T, Farris K, Volume C. Implementing pharmaceutical care: insights from Alberta community pharmacists. Can Pharm J 1999;132:41-5.
27. Wilson J, Whelan AM. Community pharmacists' views of pharmaceutical care. Can Pharm J 1995;128:31-5.
28. Odedina F, Segal R, Hepler C, et al. Changing pharmacists' practice pattern: pharmacists' implementation of pharmaceutical care factors. J Soc Admin Pharm 1996;13:74-88.
29. Bell H, McElnay J, Hughes C, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Admin Pharm 1998;15:284-94.
30. Krska J, Veitch G. Perceived factors influencing the development of primary care-based pharmaceutical care in Scotland. Int J Pharm Pract 2001;9:243-52.
31. Troein M, Råstam L, Selander S. Physicians' lack of confidence in pharmacists' competence as patient informants. J Soc Admin Pharm 1992;9:114-22.
32. Oxman AD, Thomson MA, Davis D, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995;153:1423-31.
33. Wood I. The effects of continuing professional education on the clinical practice of nurses: a review of the literature. Int J Nurs Stud 1998;35:125-31.
34. Farris KB, Kirking DM. Predicting community pharmacists' intention to try to prevent and correct drug therapy problems. J Soc Admin Pharm 1995;12:64-79.
35. Pharmacy Practice Research Roundtable. Advancing pharmacy practice through research: a 2004 perspective. J Am Pharm Assoc 2004;44:621-8.
36. Roberts AS, Hopp T, Sørensen EW, et al. Understanding practice change in community pharmacy. A qualitative research instrument based on organisational theory. Pharm World Sci 2003;25:227-34.
37. Holland RW, Nimmo CM. Transitions in pharmacy practice - part 3: effecting change - the three-ring circus. Am J Health Syst Pharm 1999;56:2235-41.
38. Murphy AL, MacKinnon NJ, Flanagan PS, et al. Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees. Ann Pharmacother 2005;39:655-61.
39. Benrimoj SI, Langford JH, Berry G, et al. Clinical intervention rates in community pharmacy: a randomized trial of the effect of education and a professional allowance. Int J Pharm Pract 2003;11:71-80.
40. Doucet MD, Purdy RA, Kaufman DM, Langille DB. Comparison of problem-based learning and lecture format in continuing medical education on headache diagnosis and management. Med Educ 1998;32:590-6.
41. Fjortoft NF, Schwartz AH. Evaluation of a pharmacy continuing education program: long-term learning outcomes in practice behaviors. Am J Pharm Educ 2003;67:35.
42. Prideaux D. Researching the outcomes of educational interventions: a matter of design. BMJ 2002;324:126-7.